This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ConclusionThe incidence of in-hospital mortality in patients undergoing coronaryarterybypassgrafting with low ejection fraction is correlated with several factors, including advanced age, LVEF, Glu, eGFR, and the standardized preoperative administration of oral nitrates and aspirin.
As the current guidelines on myocardial revascularization recommend, transit-time flow measurement (TTFM) is increasingly used for intraoperative graft flow analysis during coronaryarterybypassgrafting (CAB.
Coronaryarterybypassgrafting (CABG) is a surgical procedure that improves blood flow to the heart tissue and can effectively treat myocardial ischemia caused by coronaryartery disease.
This prespecified subgroup analysis of the FAME 3 randomized clinical trial investigates the relative treatment effect of fractional flow reserve (FFR)guided percutaneous coronary intervention vs coronaryarterybypassgraft according to diabetes status with respect to major adverse cardiac and cerebrovascular events at 3 years.
Getty Images milla1cf Mon, 01/29/2024 - 14:29 January 29, 2024 — A new study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, examines the ongoing controversy surrounding the choice between multi-arterialgrafting (MAG) and single arterialgrafting (SAG) in coronaryarterybypassgrafting (CABG) for multivessel (..)
Cardiac arrest after coronaryarterybypassgrafting (CABG) is a serious complication with low survival rate. The prognosis of patients with cardiac arrest in the general ward is worse than that in the intensi.
Patients undergoing dialysis treatment have long been recognized as having an elevated risk of developing coronaryartery disease necessitating coronaryarterybypassgrafting (CABG). However, the prognostic i.
Patients requiring coronaryarterybypassgrafting (CABG) are often loaded with antithrombotic drugs (AT) and are at an increased risk for perioperative bleeding complications. Active AT removal by a hemoadsor.
This study examined the efficacy of del Nido cardioplegia compared with traditional blood cardioplegia in adult cardiac surgery for isolated coronaryarterybypassgrafting by evaluating the early postoperativ.
Both indexes have been extensively validated in clinical trials in guiding revascularisation in patients with stable ischaemic heart disease undergoing percutaneous coronary intervention (PCI) with improved clinical outcomes. However, the role of these tools in coronaryarterybypassgrafting (CABG) is less clear.
Endoscopic vein harvesting (EVH) is an alternative technique to obtain the saphenous vein for coronaryarterybypassgrafting (CABG) surgery. We aimed to evaluate the early and mid-term outcomes of patients wi.
Tyler, Texas-based Christus Mother Frances Hospital had the lowest unplanned readmission rate for coronaryarterybypassgraft surgery in the U.S. between July 1, 2020, and July 30, 2023, according to CMS data released Oct.
Little is known about the role of D-dimer (DD) on the prognosis of patients undergoing coronary endarterectomy (CE) combined with coronaryarterybypassgrafting (CABG).
Baseline systemic inflammation is associated with worse long-term outcomes after coronaryarterybypassgrafting [CABG], but the mechanisms of this association are unclear. This study aims to explore the assoc.
based North Shore University Hospital had the lowest 30-day mortality rate for coronaryarterybypassgraft patients in the U.S. Manhasset, N.Y.-based between July 1, 2020, and June 30, 2023, according to CMS data released July 31.
Background Postoperative delirium (POD) presents as a serious neuropsychiatric syndrome in patients undergoing off-pump coronaryarterybypassgrafting (OPCABG) surgery. This is correlated with higher mortality, cognitive decline, and increased costs.
The left internal thoracic artery (LITA) has been widely accepted as the standard for revascularizing the left anterior descending artery during coronaryarterybypassgrafting (CABG) surgery. However, in 102.
We evaluated the surgical outcomes in three groups of individuals with diabetes mellitus (DM), end-stage renal disease (ESRD), and on (ONCAB) vs. off-pump (OPCAB) coronaryarterybypassgrafting (CABG).
In the context of myocardial infarction, coronaryarterybypassgraft (CABG) surgery is the prevalent therapeutic modality associated with several early and late complications. Survivors may also experience several complications. Infarct-related torsade de pointes (TdP) is an uncommon complication.
Coronaryarterybypassgrafting (CABG) surgery is a common procedure for managing multi-vessel coronaryartery disease to revascularize the myocardium. Among the various conduits used, the left internal mammar.
A 70-year-old female patient with a history of bioprosthetic aortic valve replacement and coronaryarterybypassgraft presented with bioprosthetic valve failure secondary to prosthetic valve endocarditis. This resulted in early death due to myocardial infarction and acute heart failure.
BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronaryarterybypassgrafting (CABG).
BackgroundPrevious studies proposed the predictive value of baseline serum uric acid (SUA) in the prognosis of coronaryarterybypassgrafting (CABG) patients.
The goal of the pCAD-POAF trial was to determine the efficacy and safety of partial cardiac denervation to reduce the risk of postoperative atrial fibrillation (POAF) following coronaryarterybypassgrafting (CABG).
This study is designed to investigate the impact of body mass index (BMI) on the short-term outcomes of patients undergoing off-pump coronaryarterybypassgraft (OPCAB) surgery.
For patients who are candidates for renal transplantation (RT), major surgeries such as coronaryarterybypassgrafting (CABG) are associated with cardiac complications as well as higher rates of post-operative complications, including the need for large amounts of blood transfusion, worsening kidney function, infection, and graft rejection.
Coronaryarterybypassgrafting (CABG) is associated with antithrombotic therapy in terms of postoperative adverse events; however, it is still unknown whether the early use of such drugs after CABG is safe an.
In this setting, implantation of a durable left ventricular assist device (LVAD) might be an alternative.MethodsWe retrospectively compared the outcomes of adult patients with CAD and a left ventricular ejection fraction (LVEF) ≤ 25% who underwent coronaryarterybypassgrafting (CABG) vs. LVAD implantation.
Background Atrial fibrillation (AF) following coronaryarterybypassgraft surgery (CABG) is common and results in significant increases in hospital stay and financial encumbrance. Objective Determine and use the predictors of postoperative AF (POAF) following CABG to develop a new predictive screening tool.
BackgroundWe aimed to develop an administrative model to profile the performance on the outcomes of coronaryarterybypassgrafting across hospitals in China.Methods and ResultsThis retrospective study was based on the Chinese Hospital Quality Monitoring System (HQMS) from 2016 to 2020.
To explore the impact of preoperative HbA1c levels on postoperative complications in coronary heart disease patients undergoing coronaryarterybypassgrafting (CABG).
Coronaryarterybypassgrafting(CABG) is a surgical treatment for coronaryartery disease aiming at improving symptoms and life expectancy. Despite this, there are pulmonary and functional complications that m.
The distribution and prognostic implication of lipoprotein(a) in patients undergoing coronaryarterybypassgrafting remain unknown. The adverse effects of lipoprotein(a) were more pronounced in patients with clinically low‐risk profiles or not receiving arterialgrafts.
(MedPage Today) -- SAN ANTONIO -- Researchers made a case for superior long-term survival with multi-arterialgrafts (MAGs) during multivessel coronaryarterybypassgrafting (CABG) surgery, with some arguing that this should be more widely adopted.
In a 10-year follow-up study with over 1 million patients, multi-arterialgrafting demonstrated superior long-term survival compared to single arterialgrafting.
End-Stage Renal Disease (ESRD) is an independent risk factor in outcomes for traditional coronaryarterybypassgrafting (TRAD-CAB) utilizing aortic cross-clamping and cardioplegic arrest. In order to determin.
We investigated the role of left atrial strain parameters by preoperative speckle tracking echocardiography as independent predictors of POAF in patients undergoing coronaryarterybypass graft.METHODS:Consecutive patients undergoing isolated coronaryarterybypassgraft were prospectively enrolled at three Italian centers.
Objective Saphenous vein graft disease (SVGD) remains a challenging issue for patients with coronaryarterybypassgrafting (CABG). It is associated with poor outcomes and atherosclerosis is the major cause of SVGD. Uric acid to albumin ratio (UAR) is a new marker which associated with cardiovascular mortality.
Objective Coronaryarterybypassgrafting (CABG) is an established revascularisation strategy for multivessel and left main coronaryartery disease. Although aspirin is routinely recommended for patients with CABG, the optimal antiplatelet regimen after CABG remains unclear.
This randomized clinical trial examines whether a partial cardiac denervation procedure reduces the incidence of postoperative atrial fibrillation among patients undergoing isolated coronaryarterybypassgrafting (CABG) in China.
This robot assists surgeons in performing coronaryarterybypassgrafting (CABG) through a minimally invasive approach which leaves patients with less pain and a shorter recovery after surgery. They’re going to have more freedom from re-intervention, and they don't have to have a big sternotomy.”
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content